Paliperidone

Schizophrenia: Paliperidone Extended-Release Tablets are indicated for the treatment of schizophrenia

The efficacy of Paliperidone in schizophrenia was established in three 6-week trials in adults and one 6-week trial in adolescents, as well as one maintenance trial in adults.

Schizoaffective Disorder: Paliperidone Extended-Release Tablets are indicated for the treatment of schizoaffective disorder as monotherapy and an adjunct to mood stabilizers and/or antidepressant therapy

The efficacy of Paliperidone in schizoaffective disorder was established in two 6-week trials in adults.

There are no products to list in this category.

Continue